The next few quarters should continue to see decent growth, on the back of increased patient volume from China following the launch of the sales representative office
Alpha said that 2Q25 continued to see a high foreign patient mix, in part due to maiden contribution from the SRO in Shanghai, China. A full quarter’s contribution from the China SRO and the establishment of a satellite clinic in Jakarta, Indonesia should support overall patient volume
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
bosskubakery
51 posts
Posted by bosskubakery > 1 week ago | Report Abuse
Higher sales figures are mostly from foreign patients, good move for Alpha to keep expanding towards China and South East Asia.